ing more widely used in the United States today in the treatment of hypertension and the treatment of angina. Angina may be caused by a spasm of the coronary arteries or blockage of the coronary arteries from atherosclerosis. Hypertension is a hemodynamic abnormality in which the cardinal disturbance is an increase in total peripheral resistance, probably caused by neurogenic or humoral mechanisms.
There is a growing trend toward the use of alternative agents in the treatment of hypertension. In the United States, beta blockers are the most popular alternative to diuretics, and their use as initial therapy has been sanctioned by the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure (1984) . The calcium channel blockers are widely used as initial antihypertensive therapy in Europe, and have become the most recent entrant into the field of antihypertensive agents used in the United States today. Calcium channel blockers are also used to relieve or prevent the pain of angina. Nitrates remain the first line drug with beta-blockers added to the regimen. If nitrates and beta-blockers fail to relieve the pain, calcium channel blockers may be added. With Printzmetal angina, which is an atypical form of angina, nitrates are still the first line drug. However, beta-blockers are not added since they may cause vas-Calcium entry blocking drugs reduce systolic blood pressure by decreasing peripheral vascular resistance and improving blood flow to the myocardium, kidneys, and brain.
ospasm. Instead, calcium channel agents are substituted because they can reverse the vasospasm.
CALCIUM ENTRY BLOCKERS WORK
Calcium entry blocking drugs reduce systolic blood pressure by decreasing peripheral vascular resistance and improving blood flow to the myocardium, kidneys and brain. The major effect is to reduce myocardial oxygen demand. Individual calcium entry blockers differ in regard to their effects on the myocardium but affect pacemaker activity, atrioventricular conduction, and myocardial contractility. Calcium channel agents inhibit the flow of calcium ions into the myocardial cells dur-ing depolarization of the heart. This reduction of calcium ions decreases myocardial contractibility. With the reduction in contractility, the heart needs less oxygen.
Calcium blockers also affect excitationcontraction coupling of smooth muscle in the coronary, renal and peripheral vasculature and stimulus-secretion coupling (juxtaglomerular cell renin secretion). In vascular smooth muscle, as well as in skeletal muscle, the physiologic regulation of muscle contraction is determined by the concentration of ionized intracellular calcium. The degree of contraction or relaxation of vascular smooth muscle reflects the level of intracellular calcium concentration and is dependent on the opening of calcium channels within the cell membrane. The sources of calcium are either intracellularly sequestered or in the extracellular fluid.
Stimulation of the calcium channels in vascular smooth muscle causes calcium to influx from the extracellular space. These calcium channels are receptor operated and activated by drugs such as norepinephrine. Calcium channel blockers block some of the channels of flow of calcium from the extracellular space. When the calcium levels fall as a result of the calcium channel blockers, muscle relaxation occurs and the peripheral arteries dilate. Since the calcium channel blockers also affect the smooth muscle cells of the coro-nary arteries, coronary artery delitation and reversal of coronary artery spasm also occur. This vasodilitation causes an improvement in the perfusion of the myocardium and also an increase in oxygen supply. Cells in the sinus node and the atrioventricular node also rely heavily on the calcium current.
Calcium channel blocking drugs have a depressant action on the sinoatrial node which may decrease the heart rate especially in supraventricular tachycardias and decreases oxygen demand since myocardial oxygen consumption is also directly related to heart rate. Calcium channel blockers produce coronary vasodilitation, decreases myocardial contractility, systemic arterial vasodilitation and many reverse or prevent coronary artery vasoconstriction. Calcium entry blockers thus improve myocardial blood flow while decreasing cardiac oxygen demand secondary to systemic vasodilatation. This also makes them effective agents for people with ischemic heart disease to reduce the frequency of angina attacks by both coronary and peripheral vasodilitation. Calcium blockers are effective in the treatment of Prinzmetal's angina. In this angina, pain occurs at rest and is caused by coronary vasospasm.
The renin-angiotensin-aldosterone system regulates blood pressure and volume homeostasis as well as sodium and potassium metabolism. Certain hypertensive people have either an inappropriate excess of renin activity while others have suppressed levels of plasma renin activity. In high renin hypertension, the excess pressure is usually renin dependent, while in low renin states the renin system is not dependent on renin activity but acts as if an excess of volume factors is present (Laragh & Sealey, 1981) .
Serum Ca + + is directly related to plasma renin activity; low renin subjects have lower average Ca + + than either high renin hypertensive or normotensive control subjects. Calcium channel blockers have been found to be particularly potent as antihypertensive agents in patients with low renin hypertension, especially with elderly patients (Kirkendall, 1986; Muller, Bolli, Erne, Kowski & Buhler, 1986) . None of the calcium entry blockers adversely affects renal function, glomerular filtration rate, or renal plasma flow (Buhler, Bolli, Krowski, Erne, Hulthon & Block, 1984) .
OTHER NON-CARDIAC USES OF CALCIUM ENTRY BLOCKERS
Calcium channel blockers have non-cardiac uses. They are used for pulmonary arterial hypertension, cerebral artery Individual calcium entry blockers differin regard to their effects on the myocardium but affect pacemaker activiã trioventricular conduction, and myocardial contractilih ypertension, digital vasopastic disease, migraine headaches, bronchial asthma, esophageal hypermotility, uterine hyperactivity and bladder hyperactivity.
COMPARISON OF MAJOR CALCIUM BLOCKER DRUGS AND RELATED NURSING IMPLICATIONS
Nifedipine is a potent vasodilator that acts on the vascular beds. It is used chiefly in the treatment of angina. The drug lowers blood pressure, increases cardiac output and increases heart rate due to sympathetic stimulation. Low renin hypertensive patients respond better than high renin hypertensive to nifedipine. Nifedipine is rapidly and completely absorbed following oral administration with peak plasma levels 30-60 minutes later. It can be given orally or sublingually. It is metabolized by the liver. Side effects include headache, facial flushing, peripheral edema, and burning in the face and legs.
Verapamil reduces systemic vascular resistance, decreases myocardial contractility and heart rate. Verapamil inhibits the calcium influx into the myocardial conduction fibers as well as the myocardial contractile fibers. Verapamil inhibits this influx in the sinoatrial node (SA) and atrioventricular (AV) node. This depresses the impulse generation in the SA node and prolongs conduction in the SA node. Since calcium channel drugs can cause hypotension it is important for the nurse to establish a baseline blood pressure before starting therapy. The client should be instructed how to take a blood pressure and pulse and take these on a regular basis at home. The hypotension may also cause dizziness or lightheadedness so the client must be cautioned about this effect if operating equipment or driving a vehicle.
Although congestive heart failure is a rare side effect, the nurse should instruct the client to be aware of any joint or foot swelling, difficulty breathing, or increased frequency of urination at night. It is important for the client to monitor weight and weigh at least weekly. me people most susceptible to congestive failure are those taking both a beta blocking agent and a calcium channel agent. If the client becomes constipated, the nurse should explain dietary changes to promote normal bowel elimination. Foods high in fiber and increasing fluids are two helpful dietary modifications. The client may need a stool softener or an over-the-counter bulk laxative.
The drug is contraindicated in patients with moderate to severe heart failure, sick sinus syndrome and A-V conduction abnormality (Schneck, 1985) . It is metabolized also by the liver with peak plasma levels occurring one to two hours after oral administration. When verapamil is given intravenously, lower blood pressure occurs between one to five minutes after the injection with a maximal drop in two to five minutes after a bolus, 10-15 minutes after continuous infusion. Co-administration of verapamil with digoxin can lead to increases in plasma digoxin levels which can cause toxic effects. Bradycardia is one of the first signs of which the nurse should be alert. Other signs are anorexia, nausea, fatigue, muscle weakness, or blurred or yellow green vision. The nurse should explain to the client that if any of the above occur, notify the physician immediately.
Verapamil may never be given with quinidine as the combination of both drugs can cause serious hypotension. Verapamil is the calcium antagonist with the most clearly defined antiarrhythmic properties and acts by slowing the conduction of the A-V node. It is used to terminate paroxysmal supraventricular tachycardia and slow the ventricular response in atrial flutter and fibrillation. It may be given as a single bolus of 10 mg (0.15 mg/kg of body weight) or prophylactically over a two-to three-day period of80 mg po qid. The most common side effects of verapamil include constipation, vertigo, dry mouth and thirst, heart block, and nausea and vomiting (Schneck, 1985) .
Diltiazem acts primarily in the arterial resistance vessels and is also metabolized in the liver, but little data are available on its pharmacodynamics. Diltiazem does prove to be an effective antihypertensive agent in black patients with its blood pressure lowering effect equivalent to hydrochlorathiazide (Moser, Lunn, & Materson, 1985) . It is also used in typical and Prinzmetal's angina. Side effects are minimal with headache being the major reported side effect as well as some peripheral edema. Diltiazem is given orally, 60-80 mg tid. Its action starts within 15 minutes and reaches its peak effectiveness in 30 minutes (Kirkendall, 1986) .
OTHER RELATED NURSING IMPLICATIONS
Most of the studies have been done on fasting subjects. However, some studies indicate that administration of a carbohydrate rich or protein lipid meal may decrease metabolism of calcium blockers. Clients should be advised to take these drugs on an empty stomach or before meals. Since these drugs are metabolized in the liver, dosages should be decreased and lab results of the patients monitored closely if the patient has liver disease. The nurse should stress to the client to take the medication as prescribed and to go to the physician for regular medical check-ups. If the drugs were discontinued, the oral dosage should be decreased daily over a period of two weeks. The client should be taught how to take the blood pressure and pulse in case cardiovascular rebound occurs.
Elderly patients should have reduced drug dosage due to decreases in hepatic blood flow and oxidation by the liver. This is also true for uremic patients as well as elderly patients in whom renal function is compromised. Verapamil and diltiazem appear safe for diabetic patients although nifedipine should be used with caution (Piepho, 1985) . Calcium blocking agents have a bronchodilator rather than a bronchospastic action which is safer for patients with bronchial diseases (Anderson, 1985) .
DRUG INTERACTION AND OTHER IMPLICATIONS FOR HEALTH TEACHING
Calcium-entry blockers interact with many other drugs. Since diltiazem and verapamil affect atrionodal depression, the drugs quinidine and procainamide and digoxin may have an additive effect and have already been discussed. Cimetidine reduces hepatic blood flow and inhibits oxidati ve function. Patients using both cimitidine and verapamil must be closely
The OHN must be aware of the actions, side effects, and drug interactions to give safe nursing care to those people receiving calcium blocking drugs. observed for hypotension, constipation, A-V nodal depression. Cigarette smoking stimulates both heart rate and hepatic oxidati ve processes and causes an increased myocardial oxygen demand.
Smoking is antagonistic to nifedipine. Clients should be encouraged to reduce or eliminate smoking. In addition, calcium blocking agents may interact with antidiabetic medications and other agents such as the phenothiozine antipsychotic drugs or tricyclic antipressents. This may cause unwanted side-effects.
SUMMARY
Calcium blocking drugs are becoming more widely utilized in the therapeutic intervention of patients with cardiac disease, particularly hypertension and angina. The occupational health nurse must be aware of the actions, side effects and drug interactions to give safe nursing care to those people receiving these drugs. Health teaching of these people is vital since many of the side-effects of these drugs such as hypotension can lead to onthe-job injury. Simple health teaching such as blood pressure and pulse monitoring are important to the client's safety and wellbeing. Since one of the most frequent nursing diagnoses of the patient with hypertension is non-compliance or knowledge deficit, it is important for the nurse to encourage taking medication as prescribed and to instruct the client as to the problems that can occur if the drug regimen is not followed.
